High-resolution respirometry reveals altered mammalian tissue ketone body oxidation in different cardiometabolic diseases

Elric Zweck,Sarah Piel,Johannes Schmidt,Daniel Scheiber,Martin Schoen,Sabine Kahl,Volker Burkart,Bedair Dewidar,Ricarda Remus,Alexandra Chadt,Hadi Al-Hasani,Hug Aubin,Udo Boeken,Artur Lichtenberg,Amin Polzin,Malte Kelm,Ralf Westenfeld,Robert Wagner,Julia Szendroedi,Michael Roden,Cesare Granata
DOI: https://doi.org/10.1101/2024.06.27.600966
2024-06-27
Abstract:Abnormal mitochondrial oxidative phosphorylation (OXPHOS) is key to the pathogenesis of several cardiometabolic diseases. The ketone bodies (KBs), beta-hydroxybutyrate (HBA) and acetoacetate (ACA), are critical for tissue-specific energy metabolism under various pathophysiological conditions. However, robust methods quantifying their contribution as substrates for OXPHOS are lacking. Here, we first established comprehensive high-resolution respirometry protocols for assessing the differential contributions of HBA, ACA, and related ketolytic enzymes to OXPHOS in translational studies in mice and humans. We then utilized these protocols to demonstrate (i) organ-specific differences in KB-driven mitochondrial respiration in mice, (ii) lower KB-driven mitochondrial respiration in liver of humans with steatosis, skeletal muscle of humans with diabetes and in kidney of diet-induced obese mice, as well as (iii) higher mitochondrial KB utilization capacity in mouse and human failing heart. These results highlight organ-specific roles of KB metabolism in cardiometabolic diseases and shall help to identify novel targets in these pathways.
Cell Biology
What problem does this paper attempt to address?